Study of CL22205 for menstrual pain and quality of life
Part of Women’s health & pregnancy clinical trials.
This study tests a new product called CL22205 to see if it can reduce menstrual pain and improve quality of life. It is for women with longer menstrual cycles (36-45 days) who have moderate to severe period pain.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman aged 25 to 35 years.
- Your menstrual cycles are usually between 36 and 45 days apart.
- You have moderate to severe period pain (at least 40 on a 0-100 pain scale) for at least the last two cycles.
- You have a body mass index (BMI) between 20 and 29.9.
- You are a non-smoker and do not drink alcohol.
- You are willing to use non-hormonal birth control during the study if you are sexually active.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new supplement, CL25216, to see if it helps balance hormones and reduce period pain. It is for women who have regular periods but suffer from painful cramps.
This Phase 3 study tests whether CDE100 can reduce menstrual cramp pain in people with primary dysmenorrhea (cramps that are not caused by another medical condition). It also checks how safe the treatment is and how it’s tolerated over time.
This trial tests a device that gently stimulates a nerve in your ear to see if it eases menstrual cramps. It may offer a drug-free option for managing period pain.
This study tests a new medicine, DEH113, to see if it safely reduces pain from menstrual cramps in people with primary dysmenorrhea (cramps not caused by another condition). It may offer another option for managing period pain.
This study tests a new supplement called CL22205 to see if it can improve bone density and help with menopausal symptoms. It is designed for women aged 55-65 who have gone through menopause and have early bone loss (osteopenia).
This trial tests an experimental drug called HMI-115 to see if it reduces pain from endometriosis. If you have moderate to severe period pain and non-period pain, and you have a surgical diagnosis, you may be able to join.
Hear when a new Menstrual Discomfort trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.